Voisin Consulting Life Sciences post icon
Press release

VCLS announces today partnership agreement with iliomad Health Data

Post thumbnail VCLS announces today partnership agreement with iliomad Health Data

Paris, September 14th 2020 – Voisin Consulting Life Sciences (VCLS), a leading global HeathTech product development consultancy, today announced a partnership agreement with iliomad Health Data (iliomad).

The General Data Protection Regulation 2016/679 (GDPR) has come into force on May 25th, 2018. This new European regulation intends to empower and protect the data privacy of all EU natural persons and to reshape the way organizations are working with personal data. Such regulation has profound consequences on the planning and conduct of clinical trials. Understanding whether and how GDPR impacts the clinical trial is pivotal for the protection of patients and their personal data, as well as the data of all other individuals involved in clinical trials.

Through this partnership, VCLS and iliomad aim at developing GDPR services and digital tools to help maintain the confidentiality of private health information while allowing for the exchange of data sets among and between academics, practitioners, city labs, hospitals, biopharma, and medtech companies.

We are delighted to form such a partnership with iliomad. The combination of regulatory experts and GDPR specialists makes us a powerful support to our clients while navigating the complex, evolving HealthTech environment.” said Emmanuelle Voisin, Founder and CEO of VCLS.

“ Clinical trials are critical to the understanding of the safety and efficacy of medical innovation. The extensive regulatory and clinical experience VCLS brings places our clients at the forefront of integrated compliance strategy for their clinical trials. We are very excited about this partnership.” comments Seamus Larroque, CEO of iliomad.

About VCLS

VCLS is a global product development consultancy, which guides Biotechnology, Medtech, and Pharmaceutical manufacturers throughout product development and commercialization. From discovery to patients, VCLS assists innovators to design product development strategies that optimize clinical development to drive commercial success, through an understanding of both regulators and payers.

VCLS’s team of HealthTech product specialists seamlessly complement innovative life sciences companies’ resources with strategic advice and cross-functional operational capabilities. The firm offers integrated solutions to development planning, manufacturing, quality and controls, nonclinical and clinical testing, safety monitoring, and interactions with regulators and payers. With offices in Cambridge, Somerville (MA & NJ, USA), London (UK), Paris and Rennes (France), Lausanne (Switzerland), Copenhagen (Denmark) and Bangalore (India). VCLS serves a broad range of developers and investors.

About iliomad

iliomad Health Data is a young regulatory and technical start-up that accompanies HealthTech companies to enhance medical data to improve medical research through regulatory compliance and secured IT tools.

Led by Seamus Larroque, former Legal Counsel at VCLS, and Pierre Malvoisin former DPO at UNICANCER, iliomad through its unique set of expertise and broad experience in the medical research environment, allows healthcare actors to be compliant with the strenuous data privacy regulations (GDPR, HIPAA, CCPA, PIPEDA)  as well as providing the safest and secure tools to easily process medical data.